R&D partnerships are key to Stada's ambitious growth strategy, the company's new CHC innovation chief, Steve Makin tells HBW Insight, in the second part of an exclusive interview. CBD and probiotics are particularly exciting areas within the post-COVID wellness/prevention mega-trend, he says, in which Stada is already making headway with new products.
Stada Arzneimittel has kept its foot on the gas over the last few months, despite the challenges posed by the coronavirus pandemic.
Posting a 22% growth in turnover at its Branded Products business in the first half of the year – with a series of consumer health acquisitions across Europe and Asia driving up sales – the German group has hinted at further deals in the coming months
Reclassifying ethanol as a carcinogenic, mutagenic, or reprotoxic substance - something the European Chemicals Agency seems likely to do in the near future - would be “tantamount to a de facto ban” with “fatal consequences” for medical care in Germany, says Pharma Deutschland in a joint paper with 13 other German healthcare industry associations.
Two AESGP papers reviewing the evidence for AMR risk associated with a range of OTC antifungals and antivirals conclude there is litte to no risk associated with the responsible self-care use of such medicines.
“Protecting the environment is a shared responsibility. It is unfair to expect only two sectors to fund wastewater treatment modernization and operation,” argues AESGP director general Jurate Švarcaite.
